Poly(ADP-ribosyl)ation of proteins is a posttranslational modification mediated by poly(ADP-ribose) polymerases (PARPs) that use NAD + as substrate to form the negatively charged polymer of poly(ADPribose) (PAR). After DNA damage, PARP-1 is responsible for approximately 90% of the total cellular PARylation activity. Numerous studies showed activation of PARP-1 in various conditions associated with oxidative and nitrosative stress, such as ischemia-reperfusion injury, diabetes mellitus, and inflammation, and also proved the beneficial effects of PARP inhibitors. Several pharmacological inhibitors of PARP moved toward clinical testing for a variety of indications, including cardioprotection and malignant tumors, and in late 2014, olaparib became the first PARP inhibitor approved for human use for the therapy of ovarian cancer. These advances necessitate the detection of PARP activation in human tissues. In the present chapter, we review specific methods used to detect PARP activation in human circulating leukocytes and in human tissue sections.
Introduction
PARP-1 is an abundant nuclear enzyme present in all eukaryotic cells with the exemption of neutrophil granulocytes. It is a molecular sensor of DNA damage; its catalytic activity is stimulated more than 500-fold on binding to DNA breaks. Poly(ADP-ribose) or PAR is a polymer synthesized by PARP using NAD+ as substrate. PARP catalyzes the formation of the polymer PAR, with chain lengths ranging from 2 to 300 residues, containing approximately 2% branching in the chain. PAR becomes attached to nuclear proteins and to PARP itself (automodification). Under normal conditions, cells display low basal level of PAR polymer, which can dramatically increase in cells exposed to DNA-damaging agents (irradiation, alkylation, etc.). This increase of polymer synthesis is usually transient and is followed by a rapid degradation phase with a short half-life which can be less than 1 min. The low endogenous level of polymer in unstimulated cells and its rapid catabolism during DNA damage have been ascribed to high activity of the polymer-catabolizing enzyme poly(ADP-ribose) glycohydrolase (PARG). Therefore, the level of intracellular PAR content depends on the activity of the two enzymes: PARP and PARG [1] [2] [3] .
The resulting PAR production has three major roles: (1) PARylation of histone H1 and H2B contributes to the relaxation of chromatin and increases the access to breaks, (2) indication of the occurrence and severity of DNA damage (consequent DNA repair or cell death), and (3) recruitment of single-strand break repair (SSBR)/base excision repair (BER) factors to the damaged site [1] .
Concerning the consequences of PARP-1 activity, cells exposed to DNA-damaging agents can enter three pathways based on the intensity of stimuli. In case of mild DNA damage, PARP-1 activation results in relaxation of chromatin structure, recruitment of repair enzymes, and consequent DNA repair [1] . More severe DNA damage induces apoptotic cell death, during which caspases inactivate PARP-1 by cleaving it into two fragments [4] . Extensive DNA breakage usually triggered by a massive oxidative or nitrosative stress leads to the overactivation of PARP-1 that results in the rapid depletion of cellular NAD+ and consequently APT, leading to energy depletion and necrotic cell death [3] .
PARP-1 is important in the survival and genomic integrity of cells; however, its activation has detrimental effects in various inflammatory processes, cardiac and cerebral ischemia, and diabetes mellitus where overactivation of PARP-1 can be observed [1] [2] [3] [5] [6] [7] .
There are various methods that can be used for the estimation of PARP-1 activity in tissues and cells ( Table 1 ). In case of human studies, the availability of tissues is mostly limited to small biopsy samples. Another possibility is to measure the PARP activity of isolated circulating leukocytes that may reflect the level of systemic PARP activation and correlate with the pathophysiological condition and the effect of therapeutic agents given to the patients [8, 9] .
As neutrophils and eosinophils do not have PARP-1, in all methods, isolating mononuclear cells provides increased accuracy. (The distribution of white blood cells does not alter the results.) However, this isolation is usually based on gradient centrifugation: Especially in pathological conditions where the size and density of cells change, the resulting cell suspension contains not only mononuclear cells but other cell types and debris. While immunohistochemistry and flow cytometry provide further opportunity to separate debris and different cell types, Western blot and cell-based assay do not have this advantage.
Materials
1. Blood collection tube with heparin 10 mL.
2. Histopaque-1077 (Sigma-Aldrich). 4. If you decide overlaying the blocking serum, place slides into a humified chamber during incubation.
Dulbecco's PBS (DPBS

Isolation of Circulating Leukocytes
Immuno histochemistry
5.
In case of small biopsy slides, be aware of edge effect. The ledge of slides may show more pronounced specific and unspecific staining. Always use negative control in each staining procedure.
6. PAR staining has usually but not necessary nuclear location. Low-intensity positive staining can be present in the cytoplasm. Do not discard these stainings if the negative control slide has no or slight staining.
